Clinical Trial Update: A Study to Assess the Safety, Tolerability, PK and PD of AM1030-CREAM in Patients With Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating AM1030-CREAM in adults with atopic dermatitis has completed. The study assessed safety, tolerability, pharmacokinetics and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• AM1030-CREAM

Snippet

Sponsor: AnaMar AB | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: COMPLETED